| Active ingredient (INN) | Olanzapine |
|---|---|
| Therapeutic category | Auto-created by FDA Drug Enforcement — Foreign Manufacturer Recalls scraper |
| Controlled substance | No |
| Marketing-authorisation holders | TEVA PHARMACEUTICALS USA, INC., PAI Holdings, LLC dba PAI Pharma, Pharmaco Australia Ltd |
| Registrations on file | 28 |
| Patient information leaflet (PIL) | Not on file |
| Summary of product characteristics (SPC) | Not on file |
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| Apo | 5 mg | — | 🇦🇺 AU | — | Active |
| Apo | 7.5 mg | — | 🇦🇺 AU | — | Active |
| Apo | 10 mg | — | 🇦🇺 AU | — | Active |
| OLANZA olanzapine | 5 mg | — | 🇦🇺 AU | — | Active |
| OLANZA olanzapine | 2.5 mg | — | 🇦🇺 AU | — | Active |
| PRYZEX olanzapine | 10 mg | — | 🇦🇺 AU | — | Active |
| Olanzapine | 5mg/1 | tablet | 🇺🇸 US | TEVA PHARMACEUTICALS USA, INC. | Active |
| Olanzapine | 10mg/1 | tablet | 🇺🇸 US | TEVA PHARMACEUTICALS USA, INC. | Active |
| Olanzapine | 15mg/1 | tablet | 🇺🇸 US | TEVA PHARMACEUTICALS USA, INC. | Active |
| Olanzapine | 20mg/1 | tablet | 🇺🇸 US | TEVA PHARMACEUTICALS USA, INC. | Active |
| Olanzapine and Fluoxetine | 25; 3mg/1; mg/1 | capsule | 🇺🇸 US | TEVA PHARMACEUTICALS USA, INC. | Active |
| Olanzapine and Fluoxetine | 25; 6mg/1; mg/1 | capsule | 🇺🇸 US | TEVA PHARMACEUTICALS USA, INC. | Active |
| Olanzapine and Fluoxetine | 50; 6mg/1; mg/1 | capsule | 🇺🇸 US | TEVA PHARMACEUTICALS USA, INC. | Active |
| Olanzapine and Fluoxetine | 25; 12mg/1; mg/1 | capsule | 🇺🇸 US | TEVA PHARMACEUTICALS USA, INC. | Active |
| Olanzapine and Fluoxetine | 50; 12mg/1; mg/1 | capsule | 🇺🇸 US | TEVA PHARMACEUTICALS USA, INC. | Active |